Position in ASND
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$33,608,053
+$33,599,590 QoQ
Shares Held
126,005
+340454.1% QoQ
Ownership
0.192%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#57
of 303 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Derivatives in ASND
reported options exposure · as of Jun 30, 2026CallValue
$453,424
CallShares
1,700
PutValue
$213,376
PutShares
800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,313,978 across 124 Biotechnology names. ASND ranks #1 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
This page
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in ASND
Export CSV
36 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $453,424 | 1,700 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $33,608,053 | 126,005 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $213,376 | 800 | Put | Sole | 2026-08-03 | |
| 2026-03-31 | $594,698 | 2,600 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $846,301 | 3,700 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $8,463 | 37 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $597,072 | 2,800 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $133,914 | 628 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $980,904 | 4,600 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $59,643 | 300 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $218,691 | 1,100 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $120,820 | 700 | Call | Sole | 2025-08-13 | |
| 2025-06-30 | $17,260 | 100 | Put | Sole | 2025-08-13 | |
| 2025-06-30 | $6,973,557 | 40,403 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $93,516 | 600 | Put | Sole | 2025-05-14 | |
| 2025-03-31 | $2,468,354 | 15,837 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $151,400 | 1,014 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $134,379 | 900 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $231,846 | 1,700 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $272,760 | 2,000 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $75,827 | 556 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $272,106 | 1,800 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $4,383 | 29 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $453,510 | 3,000 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $146,353 | 1,162 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $314,875 | 2,500 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $75,570 | 600 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $177,916 | 1,900 | Call | Sole | 2023-11-21 | |
| 2023-09-30 | $290,284 | 3,100 | Put | Sole | 2023-11-21 | |
| 2023-06-30 | $232,050 | 2,600 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $600,432 | 5,600 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $471,768 | 4,400 | Put | Sole | 2023-05-15 | |
| 2022-12-31 | $793,845 | 6,500 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $671,715 | 5,500 | Put | Sole | 2023-02-14 | |
| 2022-09-30 | $340,758 | 3,300 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $134,238 | 1,300 | Put | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||